Navamedic ASA: Q4 2020 financial results
Oslo, 18 February 2021 – Navamedic ASA (OSE: NAVA) grew revenues by 17% in the fourth quarter of 2020 compared to the same quarter last year. The company reported revenues of NOK 55.3 million in the fourth quarter of 2020 with an EBITDA of negative NOK 3.7 million driven by both new product launches and investments in further growth initiatives. The company reiterates its mid- to long-term ambition of building a NOK 500 million company.“The fourth quarter of 2020 displayed strong growth in our underlying portfolio and new products introduced during the second half of the year. Key growth